- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03870477
THP Hip Fracture Plating System Study (THP)
April 18, 2022 updated by: Zimmer Biomet
Intracapsular and Intertrochanteric Fracture Fixation With the THP Hip Fracture Plating System
The objective of this study is to systematically document the clinical outcomes of THP Hip Fracture Plating System when used to treat intracapsular and intertrochanteric fractures.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Primary Endpoint:
• Revision rate due to device related complication(s) or non-union of the femur.
Secondary Endpoints:
• Radiographic and clinical fracture healing of the proximal femur using standard scoring methods.
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Eskenazi Health
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Virginia
-
Falls Church, Virginia, United States, 22042
- Inova Fairfax Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient must be 18 years of age or older.
- Patient must be eligible for an open reduction and internal fixation of the proximal femur.
- Patient must have an intracapsular or intertrochanteric fracture.
- Patient must have need for alignment, stabilization, and reduction of bone fractures.
- Patient must have ability and willingness to follow postoperative care instructions until healing is complete.
- Patient must be in good nutritional state.
- Patient must be able and willing to sign the IRB/EC approved informed consent.
Exclusion Criteria:
- Patient is a prisoner.
- Patient is a current alcohol or drug abuser.
- Patient is known to be pregnant or breastfeeding.
- Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent.
- Infection.
- Patient conditions including bloody supply limitations, obesity or insufficient quantity or quality of bone.
- Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions.
- Patient has foreign body sensitivity. Where material sensitivity is suspected or unknown, testing is to be completed prior to implantation of the device.
- Patient is expected to be non-compliant with recommended post-operative weight-bearing instructions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: THP Hip Fracture Plating System
THP Hip Fracture Plating System in Intracapsular and Intertrochanteric Femur Fractures
|
The fracture plates are contoured plates used in conjunction with telescoping lag screws that are 7.5mm in diameter with lengths ranging from 70mm to 130mm in 5mm increments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With a Revision
Time Frame: 6 weeks
|
Revision rate due to device related complication(s) or non-union of the femur.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Radiographic Fracture Healing of the Femur (RUSH)
Time Frame: 6 weeks
|
Radiographic fracture healing as seen on x-ray and defined using Radiographic Union Score for Hips (RUSH) scoring system.
The RUSH quantifies four measures of healing: cortical bridging, cortical fracture disappearance, trabecular consolidation, and trabecular fracture disappearance.
Cortical healing is assessed in four anatomic femoral neck regions (anterior, posterior, medial, lateral) and trabecular healing is measured with two assessments (fracture line disappearance and consolidation of matrix).
Each of the 10 assessed dimensions of radiographic femoral neck healing are scored 1 to 3, leading to a minimum score of 10 (no signs of healing) and a maximum score of 30 (perfect healing).
|
6 weeks
|
Average FIX-IT Score (Clinical Fracture Healing of the Femur)
Time Frame: 6 weeks
|
The Function IndeX for Trauma (FIX-IT) score is an assessment tool for patients with lower extremity fractures, incorporating pain and the ability to weight-bear.
The score utilizes two questions to assess the ability to bear weight and two questions to assess pain at the fracture site.
The maximum subtotal for each set of questions is 6 points, yielding a maximum overall score of 12 points and a minimum score (lowest weight bearing and highest pain) of 0 points.
|
6 weeks
|
Average EQ-5D-5L Score (Clinical Fracture Healing of the Femur)
Time Frame: 6 weeks
|
The EuroQol five dimensions questionnaire (EQ-5D-5L) is a five dimensional self-assessment that is comprised of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
These five dimensions can be used to index a subject's health utility on a scale of 0 to 1, where 0 is death and 1 is perfect health.
The scoring rule for EQ-5D permits scores less than 0, implying that some health states may be worse than death.
The Health Status is scored on a VAS scale of 0 to 100, where 100 ('the best imaginable health state' or 'the best health state you can imagine') to 0 ('the worst imaginable health state' or 'the worst health you can imagine').
|
6 weeks
|
Average VAS Pain Score
Time Frame: 6 weeks
|
VAS pain scale is a unidimensional measure of pain intensity.
The pain VAS is a continuous scale comprised of a horizontal (HVAS) line, 10 centimeters (100 mm) in length.
For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale])
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 16, 2019
Primary Completion (ACTUAL)
March 10, 2021
Study Completion (ACTUAL)
March 10, 2021
Study Registration Dates
First Submitted
March 8, 2019
First Submitted That Met QC Criteria
March 8, 2019
First Posted (ACTUAL)
March 12, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 12, 2022
Last Update Submitted That Met QC Criteria
April 18, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSU2017-22T
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femur Fracture
-
Orthofix s.r.l.RecruitingPertrochanteric Fracture of Femur | Intertrochanteric Fracture of Femur | Subtrochanteric Fracture of FemurItaly
-
University of FloridaRecruitingDistal Femur FractureUnited States
-
AO Clinical Investigation and Publishing DocumentationActive, not recruitingDistal Femur FractureUnited States, Switzerland
-
Nationwide Children's HospitalTerminated
-
Ilocos Training and Regional Medical CenterUnknownIntertrochanteric Fractures | Pertrochanteric Fracture | Pertrochanteric Fracture of Femur, Closed | Pertrochanteric Fracture of Femur, Open
-
University of Alabama at BirminghamCompletedSupracondylar Femur FractureUnited States
-
Hadassah Medical OrganizationUnknownProximal Femur FractureIsrael
-
Amr Gamaleldin Mahmoud Khalil GendyaCompletedGeriatrics | Distal Femur FractureEgypt
-
University Health Network, TorontoRecruiting
-
Children's Hospital Los AngelesPediatric Orthopaedic Society of North AmericaActive, not recruiting
Clinical Trials on THP Hip Fracture Plating System with telescoping lag screws
-
Prisma Health-UpstateArthrex, Inc.Enrolling by invitationIntertrochanteric FracturesUnited States